Lunai Bioworks, Inc. (LNAI)
1.93
-0.01
(-0.52%)
USD |
NASDAQ |
Sep 25, 16:00
1.90
-0.03
(-1.55%)
After-Hours: 19:59
Lunai Bioworks Net Income (Quarterly) : -2.571M for March 31, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -2.571M |
| December 31, 2025 | -1.799M |
| September 30, 2025 | 2.819M |
| June 30, 2025 | -126.73M |
| March 31, 2025 | 0.1892M |
| December 31, 2024 | -7.252M |
| September 30, 2024 | -44.21M |
| June 30, 2024 | -15.73M |
| March 31, 2024 | -51.21M |
| December 31, 2023 | -4.529M |
| September 30, 2023 | -9.175M |
| June 30, 2023 | -23.20M |
| March 31, 2023 | -4.328M |
| December 31, 2022 | -4.458M |
| September 30, 2022 | -7.700M |
| June 30, 2022 | -90.24M |
| March 31, 2022 | -6.202M |
| December 31, 2021 | -6.583M |
| September 30, 2021 | -10.41M |
| June 30, 2021 | -17.36M |
| March 31, 2021 | -4.031M |
| December 31, 2020 | -2.933M |
| September 30, 2020 | -2.397M |
| June 30, 2020 | -4.098M |
| March 31, 2020 | -1.514M |
| Date | Value |
|---|---|
| December 31, 2019 | -1.720M |
| September 30, 2019 | -4.083M |
| June 30, 2019 | 6.984M |
| March 31, 2019 | -2.730M |
| December 31, 2018 | -16.11M |
| September 30, 2018 | -0.3501M |
| June 30, 2018 | -4.889M |
| March 31, 2018 | -2.960M |
| December 31, 2017 | -1.076M |
| September 30, 2017 | -0.2258M |
| June 30, 2017 | -0.1849M |
| March 31, 2017 | -0.2462M |
| December 31, 2016 | -0.9186M |
| September 30, 2016 | -0.7932M |
| June 30, 2016 | -0.7556M |
| March 31, 2016 | -0.2076M |
| December 31, 2015 | -0.4218M |
| September 30, 2015 | -0.3503M |
| March 31, 2015 | -1.253M |
| December 31, 2014 | -0.9531M |
| September 30, 2014 | -0.5352M |
| June 30, 2014 | -0.4695M |
| June 30, 2013 | -0.0029M |
| March 31, 2013 | -0.0097M |
| December 31, 2012 | -0.0098M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
| Imunon, Inc. | -2.814M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.0209M |
| Total Expenses (Quarterly) | 2.592M |
| EPS Diluted (Quarterly) | -0.823 |
| Enterprise Value | 6.886M |
| Gross Profit Margin (Quarterly) | 47.37% |
| Profit Margin (Quarterly) | -12.30K% |
| Earnings Yield | -3.18K% |
| Normalized Earnings Yield | -947.72 |